Literature DB >> 20874639

WT1 peptide vaccine, one of the most promising cancer vaccines: its present status and the future prospects.

Yoshihiro Oka, Haruo Sugiyama.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20874639     DOI： 10.2217/imt.10.58

Source DB:  PubMed          Journal:  Immunotherapy        ISSN： 1750-743X            Impact factor:   4.196


× No keyword cloud information.
  5 in total

Review 1.  Dendritic cell-based cancer immunotherapy for colorectal cancer.

Authors:  Mikio Kajihara; Kazuki Takakura; Tomoya Kanai; Zensho Ito; Keisuke Saito; Shinichiro Takami; Shigetaka Shimodaira; Masato Okamoto; Toshifumi Ohkusa; Shigeo Koido
Journal:  World J Gastroenterol       Date:  2016-05-07       Impact factor: 5.742

2.  WT1 peptide immunotherapy for gynecologic malignancies resistant to conventional therapies: a phase II trial.

Authors:  Takashi Miyatake; Yutaka Ueda; Akiko Morimoto; Takayuki Enomoto; Sumiyuki Nishida; Toshiaki Shirakata; Yoshihiro Oka; Akihiro Tsuboi; Yusuke Oji; Naoki Hosen; Shin-ichi Nakatsuka; Satoshi Morita; Junichi Sakamoto; Haruo Sugiyama; Tadashi Kimura
Journal:  J Cancer Res Clin Oncol       Date:  2012-11-18       Impact factor: 4.553

3.  Association of Wilms' tumor 1 gene single-nucleotide polymorphism rs16754 with colorectal cancer.

Authors:  Surasak Sangkhathat; Wanwisa Maneechay; Welawee Chaiyapan; Samornmas Kanngern; Teeranut Boonpipattanapong
Journal:  Mol Clin Oncol       Date:  2015-09-16

Review 4.  The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy.

Authors:  Andrew M K Law; Elgene Lim; Christopher J Ormandy; David Gallego-Ortega
Journal:  Endocr Relat Cancer       Date:  2017-02-13       Impact factor: 5.678

5.  A new peptide vaccine OCV-501: in vitro pharmacology and phase 1 study in patients with acute myeloid leukemia.

Authors:  Yukio Kobayashi; Toru Sakura; Shuichi Miyawaki; Kazuyuki Toga; Shinji Sogo; Yuji Heike
Journal:  Cancer Immunol Immunother       Date:  2017-03-20       Impact factor: 6.968
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.